Cargando…
The Incidence of Carcinoma in Patients Dying from Leukaemia, Malignant Disorders of Plasma Cells, and Malignant Lymphoma
Autores principales: | Cornes, J. S., Jones, T. G., Fisher, Gloria B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1961
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2070900/ https://www.ncbi.nlm.nih.gov/pubmed/21772450 |
Ejemplares similares
-
Second malignancies in children treated for non-Hodgkin's lymphoma and T-cell leukaemia with the UKCCSG regimens.
por: Ingram, L., et al.
Publicado: (1987) -
Serum angiotensin-converting enzyme in malignant lymphomas, leukaemia and multiple myeloma.
por: Rømer, F. K., et al.
Publicado: (1980) -
Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network
por: Howell, Debra A, et al.
Publicado: (2013) -
Occupational cancer in Britain: Haematopoietic malignancies: leukaemia, multiple myeloma, non-Hodgkins lymphoma
por: Brown, Terry, et al.
Publicado: (2012) -
Malignant Growths (including Leukaemia) and Essential Hypertension
por: Zondek, S. G., et al.
Publicado: (1953)